Fortitude Family Office »

Tango Therapeutics shares owned by Fortitude Family Office

Quarter-by-quarter ownership of Tango Therapeutics (TNGX) shares owned by Fortitude Family Office from 13F filings

Historical chart of Fortitude Family Office investment in Tango Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tango Therapeutics held by Fortitude Family Office consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tango Therapeutics by Fortitude Family Office

Quarter filed Position value Share count Share price at filing
2024-12-31 $3.7k 1.2k 3.09
2024-09-30 $4.8k 629 7.70
2024-06-30 $5.4k 629 8.58
2024-03-31 $3.9k 490 7.94
2023-12-31 $4.9k 490 9.90

More positions owned by Fortitude Family Office

Apple Stock (AAPL)
Ishares Core S&p 500 Etf Etf (IVV)
Ishares Core Msci International Developed Markets Etf Etf (IDEV)
Knight-swift Transn Hldgs Inc Cl A Stock (KNX)
Vanguard Mid-cap Etf Etf (VO)
Dimensional Emerging Markets Core Equity 2 Etf Etf (DFEM)
Avantis U.s. Large Cap Value Etf Etf (AVLV)
Imgp Dbi Managed Futures Strategy Etf Etf (DBMF)
Ishares Core Msci Emerging Markets Etf Etf (IEMG)
Ishares Core S&p Small Cap Etf Etf (IJR)
Invesco Qqq Trust Series I Etf (QQQ)
Ishares Tips Bond Etf Etf (TIP)
Dimensional Inflation-protected Securities Etf Etf (DFIP)
Avantis International Small Cap Value Etf Etf (AVDV)
Kkr & Co Stock (KKR)

View all positions for Fortitude Family Office

Top funds holding Tango Therapeutics

Trv Gp Iv
TCG Crossover Management
EcoR1 Capital
Boxer Capital Management
Nextech Invest
T. Rowe Price Investment Management
Gilead Sciences
BlackRock
Farallon Capital Management
Vanguard Group
Balyasny Asset Management
Nantahala Capital Management
Bain Capital Life Sciences Investors
Siren
Citadel Advisors

View all funds holding Tango Therapeutics